Pollescas, Kenth Ivan .
HRN: 22-11-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/31/2022
11/07/2022
IV
380 Mg
Q8
Age With Mod Dhn; T/C PSGN
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes